Combination sequential chemotherapy in advanced reticulum cell sarcoma
نویسندگان
چکیده
منابع مشابه
Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma.
T HE CHEMOTHERAPEUTIC MANAGEMENT of patients with lymphosarcoma and reticulum cell sarcoma has usually been accomplished with single agents. The alkylating agents cyclophosphamide and chlorambucil have been widely used,’3 while of the ymca alkaloids, vincristine appears most effective.46 The efficacy of corticosteroids in varying dosages was shown several times.7’8 The remission induction rates...
متن کاملCombination Chemotherapy of Advanced
Seventy-three patients with advanced non-Hodgkin lymphoma were treated with bleomycin, Adriamycin, cyclophosphamide, vincristine (Oncovin) and prednisone (BACOP), administered intensively during a 7-wk induction course followed by intermittent cycles every 3 wk for a total of 28 wk. The objective response in 44 evaluable nonleukemic patients with diffuse histology was 86%, with 66% achieving a ...
متن کاملOcular reticulum cell sarcoma.
Although rare, ocular reticulum cell sarcoma presents a recognisable clinical pattern, as confirmed by 3 new cases. Typical patients, in their sixth and seventh decades, initially complain of gradual visual loss. Examination reveals 'uveitis' with prominent vitreous debris and/or chorioretinal infiltrative lesions. Topical steroid and mydriatic therapy is ineffective. Reticulum cell sarcoma in ...
متن کاملReticulum-cell sarcoma in infancy.
In August, 1948, at the age of 1 year, this baby girl was admitted to the surgical wards of the Royal Hospital for Sick Children, Glasgow, with a red, hot and painful swelling of the left leg of 10 days' duration. The temperature was 1010 F. and the white blood count 8,000. A diagnosis of haematogenous osteitis was made, the limb was immobilized, and, after removing venous blood for culture, pe...
متن کاملCombination Chemotherapy of Advanced Chronic
1 1 10 Blood. Vol. 60. No. 5 (November). 1982 The M-2 protocol (vincristine. cyclophosphamide. BCNU. melphalan. and prednisone) was administered monthly to 63 evaluable patients with advanced chronic lymphocytic leukemia. Complete remission (absence of all clinical and bone marrow evidence of leukemia) and partial response (>50% decrease in organ enlargement and reduction of WBC count to below ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1972
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(197203)29:3<630::aid-cncr2820290316>3.0.co;2-q